Arrowhead Pharma initiates late-stage ARO-APOC3 study for familial chylomicronemia syndrome
13 January 2022 - 12:09AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Arrowhead Pharmaceuticals (NASDAQ:ARWR)
Historical Stock Chart
From Apr 2023 to Apr 2024